Seminar on Biopharmaceutical Quality Assessment
In the realm of biopharmaceuticals, the complexities surrounding quality assessment arise from the unique properties of biological products. Unlike standard pharmaceuticals, biopharmaceuticals, such as antibody drugs and regenerative medicine products, are derived from living cells and complex molecules. This creates scenarios where the manufacturing outcomes and quality attributes are not always clearly defined as either acceptable or unacceptable. Consequently, even products that meet established standards may still leave room for uncertainty, necessitating more nuanced decision-making beyond mere compliance with requirements.
To address these challenges, the I.R. Engineer Education Institute recently announced a seminar titled ‘Quality Assessment of Biopharmaceuticals: Challenges Beyond GMP.’ This online seminar is designed to help professionals in the field better understand the grey areas that can present themselves during quality assessments.
Seminar Overview
- - Course Title: Quality Assessment of Biopharmaceuticals: Challenges Beyond GMP
- - Format: Online (Live Zoom session with archived recordings)
- - Live Session Date: June 22, 2026, from 1:00 PM to 5:00 PM
- - Archive Availability: June 24, 2026, to July 8, 2026
- - Fee: ¥49,500 (tax-inclusive) per participant (discount available for multiple attendees)
- - Instructor: Satoshi Suzuki, Instructor at the Japan Pharmaceutical Support Association.
Course Content
The seminar will cover various aspects that complicate quality assessments in biopharmaceuticals, discussing critical transitions from early Chemistry, Manufacturing, and Controls (CMC) to commercialization and the challenges involved in material change, technology transfer, and scale-up processes.
Seminar Program
1.
Chapter 1: Understanding the Difficulties in Quality Assessment of Biopharmaceuticals [Background and Premise]
2.
Chapter 2: Identifying Common Sources of Grey Zone Quality [Typical Patterns]
3.
Chapter 3: Why Scientifically Accurate Explanations Fail to Pass Regulatory Scrutiny [Regulatory Perspective]
4.
Chapter 4: The Relationship Between GMP Documentation and CTD [The Exit for Quality Assessments]
5.
Chapter 5: Insights into Practical Decision Making [Quality Assurance and Organizational Reality]
6.
Chapter 6: Company Responsibilities for Assessment and Accountability [Summary and Practical Applications]
Target Audience
This seminar is tailored for professionals involved in research and development, CMC, manufacturing, quality assurance (QA), and quality control (QC) within the pharmaceutical and biopharmaceutical sectors. Ideal attendees include:
- - Technical personnel engaged in quality assessment and shipment decisions concerning biopharmaceuticals, regenerative medicine products, and nucleic acid medicines.
- - Individuals already familiar with GMP and various guidelines but facing difficulties in judgment situations that extend beyond mere specifications and procedures.
- - Experts experiencing challenges in harmonizing quality judgments across departments.
- - Project leaders or management teams requiring a strategic approach to quality oversight, especially regarding change management and post-market responses.
For further details regarding this seminar, please visit the I.R. Engineer Education Institute's official website at
https://nihon-ir.jp/seminar/biopharmaceutical_quality-assessment/.
The I.R. Engineer Education Institute is dedicated to providing valuable knowledge and skills to professionals through technical education services, including webinars, e-learning, training, and publications.
About Japan I.R. Co., Ltd.
With over 50 years of experience, Japan I.R. Co., Ltd. specializes in intellectual property solutions, including patent and intellectual property information services, technical education for the manufacturing sector, and the production of industry-focused content. For more information, visit our main site at
https://nihon-ir.jp/ or the I.R. Engineer Education Institute at
https://engineer-education.com/. Contact us at 3-6206-4966, located at 15-1 Kanda Iwamotocho, Chiyoda-ku, Tokyo, 101-0033.